Delivery Order SPE2DB24D2208-SPE2DB25FHHMV
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,338.11 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets, with a period of performance through July 3, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,158.70, is for the delivery of Candesartan Cilexetil 8 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,227.13 firm fixed-price delivery order is for the supply of Candesartan Cilexetil 16 mg tablets. The contract is not set-aside and has an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $5,666.28 and a completion date of January 8, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with any set-aside requirements, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,236.17, is a delivery order for the supply of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of December 17, 2024 and is a firm fixed price contract. AmerisourceBergen Drug Corp is the prime contractor, and there are no set-aside requirements indicated for this award. This...
This federal contract award, valued at $4,264.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract has an ultimate completion date of December 20, 2024. This contract is not designated as a set-aside and is for open competition. AmerisourceBergen, as the prime...
This federal contract award, with the ID SPE2DB22D1041|SPE2DB24FUDG5, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a firm fixed price of $5,790.32 and an ultimate completion date of August 21, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,589.04 and provides for the delivery of 4,567,269,572 Candesartan Cilexetil 8 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,787.82 firm fixed-price delivery order is for the supply of 4,566,960 units of Candesartan Cilexetil 16 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FREB3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,639.37 firm-fixed-price delivery order contract is for the supply of Candesartan Cilexetil 16 mg tablets. The contract is not designated as a set-aside. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...